Search

Your search keyword '"Hansel, Nadia"' showing total 221 results

Search Constraints

Start Over You searched for: Author "Hansel, Nadia" Remove constraint Author: "Hansel, Nadia" Publisher american thoracic society Remove constraint Publisher: american thoracic society
221 results on '"Hansel, Nadia"'

Search Results

1. Disparities in Discharge Support Provided to Patients Leaving "Before Medically Advised" from Hospitalization for Chronic Obstructive Pulmonary Disease Exacerbation.

2. Call to Action: How Can We Promote the Development of New Pharmacologic Treatments in Chronic Obstructive Pulmonary Disease?

Catalog

Books, media, physical & digital resources

3. Air Pollution Exposure and Interstitial Lung Features in SPIROMICS Participants with Chronic Obstructive Pulmonary Disease.

4. Vessel and Airway Characteristics in One-Year CT-defined Rapid Emphysema Progression: SPIROMICS

5. The Effect of Chronic Altitude Exposure on COPD Outcomes in the SPIROMICS Cohort

6. Vessel and Airway Characteristics in One-Year Computed Tomography–defined Rapid Emphysema Progression: SPIROMICS.

7. Indoor Pollution and Lung Function Decline in Current and Former Smokers: SPIROMICS AIR

8. Repeatability of Pulmonary Quantitative Computed Tomography Measurements in Chronic Obstructive Pulmonary Disease

9. Early Evidence of COPD Obscured by Race-Specific Prediction Equations

10. Diffusing Capacity as a Predictor of Hospitalizations in a Clinical Cohort of Chronic Obstructive Pulmonary Disease.

13. Tiny Particles, Big Health Impacts.

14. Diffusing Capacity and Mortality in Chronic Obstructive Pulmonary Disease

16. Repeatability of pulmonary quantitative CT measurements in a multi-center study: SPIROMICS.

17. Indoor Air Pollution and Impaired Cardiac Autonomic Function in Chronic Obstructive Pulmonary Disease

19. Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort: An Observational Cohort Study

20. Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage Chronic Obstructive Pulmonary Disease

21. Reconsidering the Utility of Race-Specific Lung Function Prediction Equations

22. Home Dust Allergen Exposure Is Associated with Outcomes among Sensitized Individuals with Chronic Obstructive Pulmonary Disease

23. Randomized Clinical Trial of Air Cleaners to Improve Indoor Air Quality and Chronic Obstructive Pulmonary Disease Health: Results of the CLEAN AIR Study

24. Alpha-1 Antitrypsin MZ Heterozygosity Is an Endotype of Chronic Obstructive Pulmonary Disease

25. Comparative Impact of Depressive Symptoms and FEV1% on Chronic Obstructive Pulmonary Disease

26. Indoor Air Pollution and Impaired Cardiac Autonomic Function in Chronic Obstructive Pulmonary Disease.

27. Clinically Significant and Comorbid Anxiety and Depression Symptoms Predict Severe Respiratory Exacerbations in Smokers: A Post Hoc Analysis of the COPDGene and SPIROMICS Cohorts

28. Defining Resilience to Smoking-related Lung Disease: A Modified Delphi Approach from SPIROMICS

29. Metformin: Experimental and Clinical Evidence for a Potential Role in Emphysema Treatment

30. Racial Segregation and Respiratory Outcomes among Urban Black Residents with and at Risk of Chronic Obstructive Pulmonary Disease

31. Mucus Plugs and Emphysema in the Pathophysiology of Airflow Obstruction and Hypoxemia in Smokers

32. Contribution of Individual and Neighborhood Factors to Racial Disparities in Respiratory Outcomes

33. The Effects of Rare SERPINA1 Variants on Lung Function and Emphysema in SPIROMICS

36. Disease Progression Modeling in Chronic Obstructive Pulmonary Disease

37. Ambient Air Pollution and Variation in Multiple Domains of Asthma Morbidity among Peruvian Children

39. Biomarkers Predictive of Exacerbations in the SPIROMICS and COPDGene Cohorts

40. A Genetic Risk Score Associated with Chronic Obstructive Pulmonary Disease Susceptibility and Lung Structure on Computed Tomography

42. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease

43. Omega-3 and Omega-6 Intake Modifies Asthma Severity and Response to Indoor Air Pollution in Children

46. Alignment of Inhaled Chronic Obstructive Pulmonary Disease Therapies with Published Strategies. Analysis of the Global Initiative for Chronic Obstructive Lung Disease Recommendations in SPIROMICS

47. Occupational Exposures and Computed Tomographic Imaging Characteristics in the SPIROMICS Cohort

48. Longitudinal Phenotypes and Mortality in Preserved Ratio Impaired Spirometry in the COPDGene Study

49. Spirometric Volumes and Breathlessness across Levels of Airflow Limitation: The COPDGene Study

50. Rural Residence and Chronic Obstructive Pulmonary Disease Exacerbations. Analysis of the SPIROMICS Cohort